Literature DB >> 17207816

The first crystal structure of phosphofructokinase from a eukaryote: Trypanosoma brucei.

José Martinez-Oyanedel1, Iain W McNae, Matthew W Nowicki, Jeffrey W Keillor, Paul A M Michels, Linda A Fothergill-Gilmore, Malcolm D Walkinshaw.   

Abstract

The crystal structure of the ATP-dependent phosphofructokinase (PFK) from Trypanosoma brucei provides the first detailed description of a eukaryotic PFK, and enables comparisons to be made with the crystal structures of bacterial ATP-dependent and PPi-dependent PFKs. The structure reveals that two insertions (the 17-20 and 329-348 loops) that are characteristic of trypanosomatid PFKs, but absent from bacterial and mammalian ATP-dependent PFKs, are located within and adjacent to the active site, and are in positions to play important roles in the enzyme's mechanism. The 90 residue N-terminal extension forms a novel domain that includes an "embracing arm" across the subunit boundary to the symmetry-related subunit in the tetrameric enzyme. Comparisons with the PPi-dependent PFK from Borrelia burgdorferi show that several features thought to be characteristic of PPi-dependent PFKs are present in the trypanosome ATP-dependent PFK. These two enzymes are generally more similar to each other than to the bacterial or mammalian ATP-dependent PFKs. However, there are critical differences at the active site of PPi-dependent PFKs that are sufficient to prevent the binding of ATP. This crystal structure of a eukaryotic PFK has enabled us to propose a detailed model of human muscle PFK that shows active site and other differences that offer opportunities for structure-based drug discovery for the treatment of sleeping sickness and other diseases caused by the trypanosomatid family of protozoan parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17207816     DOI: 10.1016/j.jmb.2006.10.019

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells.

Authors:  Andrew J Kennedy; Thomas P Mathews; Yugesh Kharel; Saundra D Field; Morgan L Moyer; James E East; Joseph D Houck; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2011-05-02       Impact factor: 7.446

2.  Crystallization and preliminary crystallographic analysis of human muscle phosphofructokinase, the main regulator of glycolysis.

Authors:  Marco Kloos; Antje Brüser; Jürgen Kirchberger; Torsten Schöneberg; Norbert Sträter
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-25       Impact factor: 1.056

3.  Identification and specific localization of tyrosine-phosphorylated proteins in Trypanosoma brucei.

Authors:  Isabelle R E Nett; Lindsay Davidson; Douglas Lamont; Michael A J Ferguson
Journal:  Eukaryot Cell       Date:  2009-01-30

4.  Subunit interactions and composition of the fructose 6-phosphate catalytic site and the fructose 2,6-bisphosphate allosteric site of mammalian phosphofructokinase.

Authors:  Cristina Ferreras; Eloy D Hernández; Oscar H Martínez-Costa; Juan J Aragón
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

5.  Evolution of allosteric citrate binding sites on 6-phosphofructo-1-kinase.

Authors:  Aleksandra Usenik; Matic Legiša
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

6.  Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in mice.

Authors:  Iain W McNae; James Kinkead; Divya Malik; Li-Hsuan Yen; Martin K Walker; Chris Swain; Scott P Webster; Nick Gray; Peter M Fernandes; Elmarie Myburgh; Elizabeth A Blackburn; Ryan Ritchie; Carol Austin; Martin A Wear; Adrian J Highton; Andrew J Keats; Antonio Vong; Jacqueline Dornan; Jeremy C Mottram; Paul A M Michels; Simon Pettit; Malcolm D Walkinshaw
Journal:  Nat Commun       Date:  2021-02-16       Impact factor: 14.919

Review 7.  Kinases as druggable targets in trypanosomatid protozoan parasites.

Authors:  Christopher Merritt; Lisseth E Silva; Angela L Tanner; Kenneth Stuart; Michael P Pollastri
Journal:  Chem Rev       Date:  2014-10-07       Impact factor: 60.622

8.  Kinetic and structural studies of Trypanosoma and Leishmania phosphofructokinases show evolutionary divergence and identify AMP as a switch regulating glycolysis versus gluconeogenesis.

Authors:  Peter M Fernandes; James Kinkead; Iain W McNae; Monserrat Vásquez-Valdivieso; Martin A Wear; Paul A M Michels; Malcolm D Walkinshaw
Journal:  FEBS J       Date:  2020-01-08       Impact factor: 5.542

9.  The Phosphofructokinase Isoform AtPFK5 Is a Novel Target of Plastidic Thioredoxin-f-Dependent Redox Regulation.

Authors:  Natalia Hess; Simon Richter; Michael Liebthal; Karl-Josef Dietz; Angelika Mustroph
Journal:  Antioxidants (Basel)       Date:  2021-03-07

10.  Digalloyl Glycoside: A Potential Inhibitor of Trypanosomal PFK from Euphorbia abyssinica J.F. Gmel.

Authors:  Seham S El-Hawary; Rabab Mohammed; Nadia M Lithy; Sameh Fekry AbouZid; Mostafa A Mansour; Suliman A Almahmoud; Bader Huwaimel; Elham Amin
Journal:  Plants (Basel)       Date:  2022-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.